US Stock MarketDetailed Quotes
LRMR Larimar Therapeutics
- 6.640
- +0.460+7.44%
Close Nov 27 16:00 ET
- 6.700
- +0.060+0.90%
Post 20:01 ET
423.68MMarket Cap-5773P/E (TTM)
6.660High6.073Low644.58KVolume6.260Open6.180Pre Close4.16MTurnover2.04%Turnover RatioLossP/E (Static)63.81MShares13.68052wk High2.14P/B209.95MFloat Cap3.34052wk Low--Dividend TTM31.62MShs Float664.320Historical High--Div YieldTTM9.50%Amplitude1.530Historical Low6.455Avg Price1Lot Size
About Larimar Therapeutics Company
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Company Profile
SymbolLRMR
Company NameLarimar Therapeutics
Listing DateJun 19, 2014
Issue Price16.00
Founded2005
CEODr. Carole Ben-Maimon, M.D.
MarketNASDAQ
Employees42
Fiscal Year Ends12-31
Address3 Bala Plaza East,Suite 506
CityBala Cynwyd
ProvincePennsylvania
CountryUnited States of America
Zip Code19004
Phone1-844-511-9056
Websitehttp://larimartx.com
Company Executives
- Name
- Position
- Salary
- Dr. Carole Ben-Maimon, M.D.
- Director, President and Chief Executive Officer
- 3.14M
- Dr. Russell G. Clayton, D.O.
- Chief Medical Officer
- --
- Dr. Gopi Shankar, F.A.A.P.,M.B.A.,PhD
- Chief Development Officer
- 1.38M
- Michael Celano
- Chief Financial Officer and Principal Accounting Officer
- 1.42M
- Joseph Truitt
- Chairman of the Board
- 114.96K
- Thomas Edward Hamilton
- Independent Director
- 77.77K
- Dr. Jeffrey W. Sherman, F.A.C.P.,M.D.
- Independent Director
- 56.43K
- Jonathan S. Leff
- Independent Director
- 79.96K
- Frank E. Thomas
- Independent Director
- 86.21K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data